Early atherosclerosis changes in children with juvenile idiopathic arthritis;Wczesne zmiany miażdżycowe u dzieci chorych na młodzieńcze idiopatyczne zapalenie stawów

Polski Merkuriusz Lekarski

Volumn 22, Issue 129, 2007, Pages 211-214

  Pietrewicz, Edyta ^a   Urban, Mirosława ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Atherosclerosis; Homocystein; IMT; Juvenile idiopathic arthritis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; ATHEROSCLEROSIS; BLOOD; CASE CONTROL STUDY; CHILD; ECHOGRAPHY; FEMALE; HUMAN; INTIMA; JUVENILE RHEUMATOID ARTHRITIS; MALE; METABOLISM; PRESCHOOL CHILD; TUNICA MEDIA;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HOMOCYSTEINE; HUMANS; MALE; TRIGLYCERIDES; TUNICA INTIMA; TUNICA MEDIA;

EID: 34047160642     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Alkaabi J.K. i wsp.: Rheumatoid arthritis and macrovascular disease. Rheumatology, 2003, 42, 292-297.
2. Bacon P. i wsp.: Rheumatoid arthritis, vasculitis and atherosclerosis. Atherosclerosis and Autoimmunity, Elsevier, 2001, 301-313.
3. Bacon P. i wsp.: Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmunity Reviews, 2002, 1, 338-347.
4. Davidson J.: Juvenile idiopathic arthritis: a clinical overview. European Journal of Radiology, 2000 (33), 128-134.
5. De Maria A.: Relative risk of cardiovascular events in patients with rheumatoid arthritis. Am. J. Cardiol., 2002, 89, supl., 33D-38D.
6. Durga J. i wsp.: Homocysteine and carotid intima media thickness: a critical appraisal of the evidence. Atherosclerosis, 2004, 176, 1-19.
7. Gerli R. i wsp.: CD4+CD28 - T lymphocytes contribute to early atherosclerosis damage in rheumatoid arthritis patients. Circulation, 2004, 8, 109 (22), 2774-2778.
8. Gonzalez-Juanatey C. i wsp.: Rheumatoid arthritis and accelerated atherogenesis. Circulation, 2004, 109, 328-334.
9. Gonzalez-Juanatey C. i wsp.: Increased prevalence of severe sublinical atherosclerosis findings in long term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore), 2003, 82 (6), 407-413.
10. Huemer M. i wsp.: Hyperhomocysteinemia in children with juvenile idiopathic arthritis is not influenced by methotrexate treatment and folic acid supplementation: A pilot study. Clin. Exp. Rheumatol., 2003, 21, 249-255.
11. Ilowite N.T.: Premature atheroslerosis in systemic lupus erythematosus. J. Rheum., 2000, 27, suppl., 15-19.
12. Johnson K. wsp.: Childhood arthritis: classification and radiology. Clinical Radiology, 2002, 57, 47-58.
13. Jonsson S.W. i wsp.: Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J. Rheumatol., 2001, 28 (12), 2597-2602.
14. Kumeda Y. i wsp.: Increased thickness of arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum., 2002, 46 (6), 1489-1497.
15. Larkin M.: Kilmer Mc Cully: pioneer of the homocysteine theory. Lancet, 1998, 24, 352, 1364.
16. Lazzerini P.E. i wsp.: Reduction in plasma homocysteine level inpatients with rheumatoid arthritis gived pulsed glucocorticoid treatment. Ann. Rheum. Dis., 2003, 62, 694-695.
17. Milojevic D. i wsp.: Dyslipoproteinemia and premature atherosclerosis in the pediatric rheumatoid diseases. Atherosclerosis and Autoimmunity, Elsevier, 2001, 329-333.
18. Park Y.B. i wsp.: Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum., 2002, 46 (7), 1714-1719.
19. Salonen R. i wsp.: Progression of carotid atherosclerosis amd its determinants: a population-based ultrasonography study. Atherosclerosis, 1990, 81, 33-40.
20. Salonen J.T. i wsp.: Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation, 1993, 87, suppl. 3, 1156-1165.
21. Schroecksnadel K. i wsp.: Modarate hyperhomocysteinemia and immune activation in patients with rheumatoid arthritis. Clinica Chimica Acta. 2003, 338, 157-164.
22. Seriolo B. i wsp.: Homocysteine and antiphospholipid antibodies in rheumatoid arthritis: relationship with thrombotic events. Clin. Exp. Rheumatol., 2001, 19, 5, 561-564.
23. Sitzer M. i wsp.: Internal carotid artery angle of origin. A novel risk factors for carotid atherosclerosis. Stroke, 2003, 34, 950-955.
24. Superko R.: Elevated high-density lipoprotein cholesterol, not protective in the presence of homocysteinemia. Am.J.Cardiol., 1997, 1, 79 (5), 705-706.
25. Yxfeldt A. i wsp.: Homocysteine in patients with rheumatoid arthritis in relation to inflammation and B-vitamin treatment. Scand. J. Rheumatol., 2003, 32 (4), 205-210.